Abstract
Cases of CD36 deficiency are not rare in Asian populations, foetal and neonatal alloimmune thrombocytopenia (FNAIT) caused by anti-CD36 isoantibodies appears more frequent than other HPA alloantibodies. However, little is known about the treatment of anti-CD36 mediated FNAIT in this region. A Chinese male foetus, whose mother had a history of multiple intrauterine foetal demise and/or hydrops, was diagnosed with severe FNAIT at 27 weeks of gestational age. Immunological analysis revealed total absence of CD36 on platelets and monocytes from mother, caused by a 329–330delAC mutation of the CD36 gene. Anti-CD36 and anti-HLA class I antibodies were detected in the maternal serum, whereas only anti-CD36 isoantibodies were detectable in the foetal blood sample. Serial intrauterine transfusions with red blood cells (RBC) and platelets from a CD36null donor were performed to improve the severe anaemia and thrombocytopenia. The baby (2250 g; Apgar scores 10) was delivered vaginally at 32 weeks of gestation with normal haemoglobin (186 g/L) but low platelet count (48 × 109/L). After 2 days the platelet count rose to 121 × 109/L. This report suggests that intrauterine transfusions with compatible RBC and CD36null platelets are useful in preventing the deleterious clinical effects of anti-CD36-mediated severe FNAIT.
Similar content being viewed by others
References
Kamphuis MM, Paridaans NP, Porcelijn L, Lopriore E, Oepkes D. Incidence and consequences of neonatal alloimmune thrombocytopenia: a systematic review. Pediatrics. 2014;133:715–21.
Turner ML, Bessos H, Fagge T, Harkness M, Rentoul F, Seymour J, et al. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion. 2005;45:1945–56.
Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet. 1989;1:363–6.
Peterson JA, McFarland JG, Curtis BR, Aster RH. Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. Br J Haematol. 2013;161:3–14.
Ohto H, Miura S, Ariga H, Ishii T, Fujimori K, Morita S, et al. The natural history of maternal immunization against foetal platelet alloantigens. Transfus Med. 2004;14:399–408.
Xia W, Ye X, Xu X, Ding H, Liu J, Deng J, et al. Two cases of platelet transfusion refractoriness and one case of possible FNAIT caused by antibodies against CD36 in China. Transfus Med. 2014;24:254–6.
Wu G, Zhou Y, Li L, Zhong Z, Li H, Li H, et al. Platelet immunology in China: research and clinical applications. Transfus Med Rev. 2017;31:118–25.
Silverstein RL, Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal. 2009;2:re3.
Yamamoto N, Akamatsu N, Sakuraba H, Yamazaki H, Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood. 1994;83:392–7.
Ikeda H, Mitani T, Ohnuma M, Haga H, Ohtzuka S, Kato T, et al. A new platelet-specific antigen, Naka, involved in the refractoriness of HLA-matched platelet transfusion. Vox Sang. 1989;57:213–7.
Tomiyama Y, Take H, Ikeda H, Mitani T, Furubayashi T, Mizutani H, et al. Identification of the platelet-specific alloantigen, Naka, on platelet membrane glycoprotein IV. Blood. 1990;75:684–7.
Porta C, Caporali R, Montecucco C. Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects. Haematologica. 1999;84:260–9.
Morishita K, Wakamoto S, Miyazaki T, Sato S, Fujihara M, Kaneko S, et al. Life-threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti-CD36 (Nak) isoantibody. Transfusion. 2005;45:803–6.
Kankirawatana S, Kupatawintu P, Juji T, Veerakul G, Ngerncham S, Chongkolwatana V, et al. Neonatal alloimmune thrombocytopenia due to anti-Nak(a). Transfusion. 2001;41:375–7.
Curtis BR, Ali S, Glazier AM, Ebert DD, Aitman TJ, Aster RH. Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature. Transfusion. 2002;42:1173–9.
Taketani T, Ito K, Mishima S, Kanai R, Uchiyama A, Hirata Y. Neonatal Isoimmune thrombocytopenia caused by type I CD36 deficiency having novel splicing isoforms of the CD36 gene. Eur J Haematol. 2008;81:70–4.
Okajima S, Cho K, Chiba H, Azuma H, Mochizuki T, Yamaguchi M, et al. Two sibling cases of hydrops fetalis due to alloimmune anti-CD36 (Naka) antibody. Thromb Haemost. 2006;95:267–71.
Xu X, Ye X, Xia W, Liu J, Ding J, Chen Y, et al. Studies on CD36 deficiency in South China: two cases demonstrating the clinical impact of anti-CD36 antibodies. Thromb Haemost. 2013;110:1199–206.
Brojer E, Husebekk A, Debska M, Uhrynowska M, Guz K, Orzińska A, et al. Fetal/neonatal alloimmune thrombocytopenia: pathogenesis, diagnostics and prevention. Arch Immunol Ther Exp. 2016;64:279–90.
Segata M, Chaoui R, Khalek N, Bahado-Singh R, Paidas MJ, Mari G. Fetal thrombocytopenia secondary to parvovirus infection. Am J Obstet Gynecol. 2007;196:61.e1–4.
Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med. 1993;329:1463–6.
Yougbaré I, Lang S, Yang H, Chen P, Zhao X, Tai WS, et al. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage. J Clin Investig. 2015;125:1545–56.
Santoso S, Wihadmadyatami H, Bakchoul T, Werth S, Al-Fakhri N, Bein G, et al. Antiendothelial αvβ3 antibodies are a major cause of intracranial bleeding in fetal/neonatal alloimmune thrombocytopenia. Arterioscler Thromb Vasc Biol. 2016;36:1517–24.
Bussel JB, Primiani A. Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates. Blood Rev. 2008;22:33–52.
Acknowledgements
This work was supported by the grant from National Natural Science Foundation of China (Ref. number: 81601451), by the Natural Science Foundation of Guangdong Province of China (no. 2016A030313124/no. 2016A030313123), by the German Research Foundation, Excellence Cluster Cardiopulmonary System (to S. S.), and by Science and Technology and Innovative Commission of Guangzhou City (no. 201607010007/no. 201509010009/no. 201707010021).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
All authors declare that there is no conflict of interest.
About this article
Cite this article
Xu, X., Li, L., Xia, W. et al. Successful management of a hydropic fetus with severe anemia and thrombocytopenia caused by anti-CD36 antibody. Int J Hematol 107, 251–256 (2018). https://doi.org/10.1007/s12185-017-2310-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-017-2310-5